| Today, Mon, Jul 13, 2009 | | • | Earnings Preview: Abbott Labs to report 2Q results
AP (Mon 12:18pm)
| | • | UPDATE - WHO says health workers priority for H1N1 vaccine
at Reuters (Mon 12:12pm)
| | • | 5 Dynamic Dividend Stocks
at Motley Fool (Mon 12:07pm)
| | • | [$$] JNJ Preview: Pharma Is the Catalyst
at RealMoney by TheStreet.com (Mon 8:32am)
| | Sat, Jul 11, 2009 | | • | Corrections & Amplifications
at The Wall Street Journal Online (Sat, Jul 11)
| | Fri, Jul 10, 2009 | | • | Earnings Preview: J&J sales seen down for 3rd time
AP (Fri, Jul 10)
| | • | SCENARIOS-Children go to front of flu vaccine line
at Reuters (Fri, Jul 10)
| | • | Is the News Good or Bad? Who Cares! Sell!
at Motley Fool (Fri, Jul 10)
| | • | Vertex Pulls a Wimpy
at Motley Fool (Fri, Jul 10)
| | • | Merck Strong in Cardiovasculars
Zacks.com (Fri, Jul 10)
| | • | Everything You Wanted to Know About Expiration Dates*
at Minyanville.com (Fri, Jul 10)
| | • | Everything You Want To Know About Expiration Dates*
at Minyanville.com (Fri, Jul 10)
| | Thu, Jul 9, 2009 | | • | Another Downer For Merck's Cholesterol Drugs
at Forbes.com (Thu, Jul 9)
| | • | Next bids loom for animal health assets - sources
at Reuters (Thu, Jul 9)
| | • | Trends Change, Market Doesn't: Stocks Flat Reaction
at Barron's Online (Thu, Jul 9)
| | • | Merck, Portola in $470M deal for anticlotting drug
AP (Thu, Jul 9)
| | • | REMERON(R) Now Approved in Japan for the Treatment of Depression in Adult Patients
PR Newswire (Thu, Jul 9)
| | • | ASMANEX(R) (Mometasone Furoate Dry Powder Inhaler) Now Approved in Japan for the Treatment of Bronchial Asthma in Adult Patients
PR Newswire (Thu, Jul 9)
| | • | Merck shares fall after analyst rumor over Zetia
AP (Thu, Jul 9)
| | • | Yes! It Can Handle the Pressure
at Motley Fool (Thu, Jul 9)
|
Add SGP News to My Yahoo!:
 
| |
|
2.27% Nasdaq 
Headlines
